BURLINGTON, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in November.
Jefferies London Healthcare Conference
Tuesday, November 14, 2023
London, UK
JJ Pellegrino, Chief Financial Officer, will present at 11:00 AM GMT
Stifel’s 2023 Healthcare Conference
Tuesday, November 14, 2023
Lotte NY Palace Hotel, New York City
David Roberts, President, will present at 1:50 PM ET
Piper Sandler 35th Annual Healthcare Conference
Wednesday, November 29, 2023
Lotte NY Palace Hotel, New York City
David Roberts, President, will present at 2:10 PM ET
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company’s diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
CONTACT: Contact: LeMaitre Vascular, Inc. Sandra Millar +1-781-425-1686 smillar@lemaitre.com
- Aura Announces Public Filing of Registration Statement for Proposed U.S. Public Offering - June 6, 2025
- Asante Provides Financial and Operating Results for the Quarter Ended April 30, 2025 - June 6, 2025
- Japan Smaller Capitalization Fund, Inc. Announces Initiatives to Enhance Shareholder Value - June 6, 2025
